Shine Justice (SHJ) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
9 Jun, 2026Executive summary
FY25 featured strategic organizational restructuring, leadership changes with new CEO and CFO, and a sharpened focus on personal injury (PI) and class actions, including exit from non-core areas and expansion into US mass torts.
Revenue increased to $204.4 million from $195.7 million year-over-year, driven by increased legal work and revenue per fee earner.
Adjusted EBITDA declined to $38.4 million from $45 million, impacted by increased provisions, higher employee benefits, and balance sheet strengthening.
Major investments made in technology, class action growth programs, and US international mass torts expansion.
Operating cash flows were $30.6 million, down from the prior year due to one-off class action receipts in FY24.
Financial highlights
Revenue up 4.4% year-over-year to $204.4 million, driven by core practice areas.
Adjusted EBITDA down to $38.4 million, mainly due to increased provisions, higher employee benefits, and a $9.6 million fair value loss.
Net debt increased to $53.6 million, primarily from reclassifying $18.8 million disbursement funding to borrowings, resulting in interest savings.
Gross borrowings at $71.6 million, with average cost of debt around 7%.
CapEx at $2.3 million, lower than previous years.
Outlook and guidance
FY26 outlook anticipates improved financial outcomes, with growth initiatives in PI and class actions, office expansion, improved fee earner utilization, and US mass torts strategy.
PI EBITDA margin baseline set at 20%, with ambitions to reach 25% or higher as operational improvements take effect.
Class actions segment expects further revenue growth as portfolio funding is secured, with growth weighted toward the second half of FY26.
Headcount expected to decrease as AI and technology improve efficiency.
Latest events from Shine Justice
- Net profit after tax surged 82.4% despite a 12% revenue drop, with record cash flow and higher dividends.SHJ
H2 20249 Jun 2026 - Revenue up, EBITDA down; strong PI and class action pipelines set up H2 recovery.SHJ
H1 20259 Jun 2026 - EBITDA up 77% and net profit returns, with cash flow set to normalize as settlements clear.SHJ
H1 20269 Jun 2026